Does the RYGB Common Limb Length influence Hypertension Remission and CardioMetabolic Risk Factors? Data from the GATEWAY TRIAL

Although Roux-en-Y Gastric Bypass (RYGB) results in significant weight loss and cardiometabolic risk factors improvements; there is no consensus whether limb lengths may influence these results.

Source: Surgery for Obesity and Related Diseases - November 26, 2018 Category: Surgery Authors: Carlos Aurelio Schiavon, Renato Nakagawa Santos, Eliana Vieira Santucci, Patricia Malvina Noujaim, Alexandre Biasi Cavalcanti, Luciano Ferreira Drager Tags: Original articles Source Type: research